Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity

Table 2

Effects of resveratrol on cardiac dysfunction and heart rate in anesthetized DM mice (1 month).

Group	HR (beats/min)	LVID (mm)	IVS (mm)	LVPW (mm)	% EF (%)	% FS (%)
Control	496 ± 20	3.60 ± 0.23	0.71 ± 0.05	0.82 ± 0.1	89 ± 5	62 ± 4
Resveratrol	459 ± 24	3.58 ± 0.32	0.72 ± 0.04	0.84 ± 0.15	88 ± 4.0	58 ± 4.5
DM	440 ± 26	3.59 ± 0.32	0.74 ± 0.05	0.86 ± 0.17	78 ± 5.0	49 ± 5
DM/resveratrol	465 ± 24	3.59 ± 0.38	0.73 ± 0.04	0.85 ± 0.12	84 ± 5	55 ± 4

Data are presented as means ± SEM. LVID = LV end-diastolic diameter; LVPW = LV posterior wall; IVS = interventricular septum; FS = fractional shortening; EF = ejection fraction. versus control. versus DM group.